ScholarIQanswers from OpenAlex & ORCID
Dik J. Kwekkeboom
ResearcherPublications, citations & collaboration network
Dik J. Kwekkeboom is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Dik J. Kwekkeboom have?
ScholarIQindexed works
Dik J. Kwekkeboom has 260 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Dik J. Kwekkeboom have?
ScholarIQcitation count
Dik J. Kwekkeboom has 28,448 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Dik J. Kwekkeboom?
ScholarIQh-index
Dik J. Kwekkeboom has an h-index of 82 in OpenAlex.
What is the i10-index of Dik J. Kwekkeboom?
ScholarIQi10-index
Dik J. Kwekkeboom has an i10-index of 151 in OpenAlex.
What is the OpenAlex record for Dik J. Kwekkeboom?
ScholarIQopenalex
The OpenAlex for Dik J. Kwekkeboom is on the source record.
What are the most-cited papers on Dik J. Kwekkeboom?
ScholarIQmost cited works
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
Jonathan Strosberg, Ghassan El‐Haddad, Edward M. Wolin, Andrew Hendifar, James C. Yao, Beth Chasen, Erik Mittra, Pamela L. Kunz, Matthew H. Kulke, Heather A. Jacene, David Bushnell, Thomas M. O’Dorisio, Richard P. Baum, Harshad Kulkarni, Martyn Caplin, Rachida Lebtahi, Timothy J. Hobday, Ebrahim S. Delpassand, Eric Van Cutsem, Al B. Benson, Rajaventhan Srirajaskanthan, Marianne Pavel, Jaime Font de Mora, Jordan Berlin, Enrique Grande, Nicholas S. Reed, Ettore Seregni, Kjell Öberg, Maribel Lopera Sierra, Paola Santoro, Thomas Thevenet, Jack L. Erion, Philippe Ruszniewski, Dik J. Kwekkeboom, Eric P. Krenning
ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors
Massimo Falconi, Barbro Eriksson, Gregory Kaltsas, Detlef K. Bartsch, Jaume Capdevila, Martyn Caplin, Beata Kos‐Kudła, Dik J. Kwekkeboom, Guido Rindi, Günter Klöppel, Nicholas S. Reed, Réza Kianmanesh, Robert T. Jensen, all other Vienna Consensus Conference participants
The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours
John J. Zaknun, Lisa Bodei, Jan Mueller‐Brand, Marianne E. Pavel, Richard P. Baum, Dieter Hörsch, M. Sue O’Dorisio, T. M. O’Dorisiol, James R. Howe, Marta Cremonesi, Dik J. Kwekkeboom
Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0,Tyr3]octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors
Tessa Brabander, Wouter A. van der Zwan, Jaap J.M. Teunissen, Boen L.R. Kam, Richard A. Feelders, Wouter W. de Herder, Casper H.J. van Eijck, Gaston J H Franssen, Eric P. Krenning, Dik J. Kwekkeboom
Recommendations for management of patients with neuroendocrine liver metastases
Andrea Frilling, Irvin M. Modlin, Mark Kidd, Christopher Russell, Stefan Breitenstein, Riad Salem, Dik J. Kwekkeboom, Wan-Yee Lau, Catherine Klersy, Valérie Vilgrain, Brian R Davidson, Mark Siegler, Martyn Caplin, Enrico Solcia, Richard L. Schilsky